跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,696 条关于
“FORTIFY FLOWABLE Extracellular Matrix”
全部
2,696
临床试验
1,744
药物
128
机构
61
资讯
763
6个月前
Sanara MedTech's CellerateRX Surgical Powder Shows $3,852 Cost Savings Per Patient in Spine Surgery Study
去年
TYBR Health Secures FDA 510(k) Clearance for B3 GEL System to Protect Healing Tissues in Musculoskeletal Surgery
去年
BridgeBio's BBP-418 Completes Enrollment in Phase 3 Trial for LGMD2I/R9
去年
Abcentra Initiates Phase 2b FORTIFY Trial for Novel Anti-Inflammatory Cardiovascular Therapy Orticumab
7年前
QGel's Synthetic Matrix Breakthrough Aims to Revolutionize Organoid-Based Precision Medicine
8个月前
Oxford Initiates European Enrollment for FORTIFY Trial Testing Orticumab in Post-Heart Attack Inflammation
去年
Gel4Med's G4Derm Plus Shows Rapid Healing in Complex Diabetic Foot Ulcers with Novel Biomimetic Matrix Technology
去年
IDEAYA Biosciences Navigates Oncology Landscape with Precision Medicine Approach
去年
IDEAYA Biosciences Navigates Oncology Landscape with Precision Medicine Approach
8个月前
Small Intracellular Vesicles Outperform Extracellular Vesicles in Drug Delivery and Retinal Protection
第 1 页，共 77 页
上一页
下一页
